Iron, the HFE gene, and hepatitis C

Clinics in Liver Disease

Volumn 8, Issue 4, 2004, Pages 775-785

  Eisenbach, Christoph ^a   Gehrke, Sven G ^a   Stremmel, Wolfgang ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HFE PROTEIN; IRON; RECOMBINANT INTERFERON;

BIOACCUMULATION; CHRONIC HEPATITIS; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC ASSOCIATION; HEPATITIS C; HETEROZYGOSITY; HUMAN; IMMUNE RESPONSE; IRON BLOOD LEVEL; IRON METABOLISM; IRON OVERLOAD; LIVER INJURY; LIVER TOXICITY; MUTATIONAL ANALYSIS; PROTEIN METABOLISM; REVIEW; TREATMENT INDICATION;

COMORBIDITY; DNA MUTATIONAL ANALYSIS; HEMOCHROMATOSIS; HEPATITIS C, CHRONIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; LIVER CIRRHOSIS; MEMBRANE PROTEINS; RISK FACTORS;

EID: 4744358094     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2004.06.006     Document Type: Review

References (82)

1. Q.L. Choo, G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, and M. Houghton Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome Science 244 4902 1989 359 362
2. J.G. Donahue, A. Munoz, P.M. Ness, D.E. Brown Jr, D.H. Yawn, and H.A. McAllister Jr The declining risk of post-transfusion hepatitis C virus infection N Engl J Med 327 6 1992 369 373
3. M. Martell, J.I. Esteban, J. Quer, J. Genesca, A. Weiner, and R. Esteban Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution J Virol 66 5 1992 3225 3229
4. E. Domingo, C. Escarmis, N. Sevilla, A. Moya, S.F. Elena, and J. Quer Basic concepts in RNA virus evolution FASEB J 10 8 1996 859 864
5. P. Farci, H.J. Alter, S. Govindarajan, D.C. Wong, R. Engle, and R.R. Lesniewski Lack of protective immunity against reinfection with hepatitis C virus Science 258 5079 1992 135 140
6. T. Heintges, and J.R. Wands Hepatitis C virus: epidemiology and transmission Hepatology 26 3 1997 521 526
7. S. Iwarson, G. Norkrans, and R. Wejstal Hepatitis C: natural history of a unique infection Clin Infect Dis 20 5 1995 1361 1370
8. F.V. Chisari Cytotoxic T cells and viral hepatitis J Clin Invest 99 7 1997 1472 1477
9. B. Rehermann, and F.V. Chisari Cell mediated immune response to the hepatitis C virus Curr Top Microbiol Immunol 242 2000 299 325
10. N.H. Shoukry, A. Grakoui, M. Houghton, D.Y. Chien, J. Ghrayeb, and K.A. Reimann Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection J Exp Med 197 12 2003 1645 1655
11. A. Grakoui, N.H. Shoukry, D.J. Woollard, J.H. Han, H.L. Hanson, and J. Ghrayeb HCV persistence and immune evasion in the absence of memory T cell help Science 302 5645 2003 659 662
12. A.M. Di Bisceglie, C.A. Axiotis, J.H. Hoofnagle, and B.R. Bacon Measurements of iron status in patients with chronic hepatitis Gastroenterology 102 6 1992 2108 2113
13. F. Farinati, R. Cardin, N. De Maria, G. Della Libera, C. Marafin, and E. Lecis Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis J Hepatol 22 4 1995 449 456
14. G. Barbaro, G. Di Lorenzo, G. Belloni, A. Asti, A.M. Pellicelli, and G. Barbarini Hepatic iron storage and megamitochondria formation in patients with chronic hepatitis C related to the hepatitis C virus genotype Dig Liver Dis 33 1 2001 81 83
15. C. Hezode, C. Cazeneuve, O. Coue, F. Roudot-Thoraval, I. Lonjon, and A. Bastie Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions J Hepatol 31 6 1999 979 984
16. H.L. Bonkovsky, R.W. Lambrecht, and Y. Shan Iron as a co-morbid factor in nonhemochromatotic liver disease Alcohol 30 2 2003 137 144
17. J.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, and A. Basava A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis Nat Genet 13 4 1996 399 408
18. M.J. Bennett, J.A. Lebron, and P.J. Bjorkman Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor Nature 403 6765 2000 46 53
19. J.A. Lebron, M.J. Bennett, D.E. Vaughn, A.J. Chirino, P.M. Snow, and G.A. Mintier Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor Cell 93 1 1998 111 123
20. C.A. Enns Pumping iron: the strange partnership of the hemochromatosis protein, a class I MHC homolog, with the transferrin receptor Traffic 2 3 2001 167 174
21. R.S. Britton, R.E. Fleming, S. Parkkila, A. Waheed, W.S. Sly, and B.R. Bacon Pathogenesis of hereditary hemochromatosis: genetics and beyond Semin Gastrointest Dis 13 2 2002 68 79
22. D. Trinder, C. Fox, G. Vautier, and J.K. Olynyk Molecular pathogenesis of iron overload Gut 51 2 2002 290 295
23. A. Waheed, S. Parkkila, J. Saarnio, R.E. Fleming, X.Y. Zhou, and S. Tomatsu Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum Proc Natl Acad Sci USA 96 4 1999 1579 1584
24. A. Roetto, G. Papanikolaou, M. Politou, F. Alberti, D. Girelli, and J. Christakis Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis Nat Genet 33 1 2003 21 22
25. G. Papanikolaou, M.E. Samuels, E.H. Ludwig, M.L. MacDonald, P.L. Franchini, and M.P. Dube Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis Nat Genet 36 1 2004 77 82
26. A. Bomford Genetics of haemochromatosis Lancet 360 9346 2002 1673 1681
27. A. Pietrangelo Haemochromatosis Gut 52 Suppl 2 2003 ii23 ii30
28. J.N. Feder, Z. Tsuchihashi, A. Irrinki, V.K. Lee, F.A. Mapa, and E. Morikang The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression J Biol Chem 272 22 1997 14025 14028
29. S. Tomatsu, K.O. Orii, R.E. Fleming, C.C. Holden, A. Waheed, and R.S. Britton Contribution of the H63D mutation in HFE to murine hereditary hemochromatosis Proc Natl Acad Sci USA 100 26 2003 15788 15793
30. D.H. Crawford, E.C. Jazwinska, L.M. Cullen, and L.W. Powell Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation Gastroenterology 114 5 1998 1003 1008
31. R. Moirand, A.M. Jouanolle, P. Brissot, J.Y. Le Gall, V. David, and Y. Deugnier Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives Gastroenterology 116 2 1999 372 377
32. C. Mura, O. Raguenes, and C. Ferec HFE mutations analysis in 711 hemochromatosis probands: evidence for S65C implication in mild form of hemochromatosis Blood 93 8 1999 2502 2505
33. J.W. Eaton, and M. Qian Molecular bases of cellular iron toxicity Free Radic Biol Med 32 9 2002 833 840
34. A. Pietrangelo Metals, oxidative stress, and hepatic fibrogenesis Semin Liver Dis 16 1 1996 13 30
35. K.A. Stuart, F. Busfield, E.C. Jazwinska, P. Gibson, L.A. Butterworth, and W.G. Cooksley The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients J Hepatol 28 3 1998 404 409
36. M. Sampietro, A. Piperno, L. Lupica, C. Arosio, A. Vergani, and N. Corbetta High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda Hepatology 27 1 1998 181 184
37. H.L. Bonkovsky, Q. Jawaid, K. Tortorelli, P. LeClair, J. Cobb, and R.W. Lambrecht Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis J Hepatol 31 3 1999 421 429
38. P. Carthew, R.E. Edwards, A.G. Smith, B. Dorman, and J.E. Francis Rapid induction of hepatic fibrosis in the gerbil after the parenteral administration of iron-dextran complex Hepatology 13 3 1991 534 539
39. M. Mackinnon, C. Clayton, J. Plummer, M. Ahern, P. Cmielewski, and A. Ilsley Iron overload facilitates hepatic fibrosis in the rat alcohol/low-dose carbon tetrachloride model Hepatology 21 4 1995 1083 1088
40. E. Boucher, A. Bourienne, P. Adams, B. Turlin, P. Brissot, and Y. Deugnier Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment Gut 41 1 1997 115 120
41. G. Barbaro, G. Di Lorenzo, M. Ribersani, M. Soldini, G. Giancaspro, and G. Bellomo Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype J Hepatol 30 5 1999 774 782
42. H.L. Bonkovsky, B.F. Banner, and A.L. Rothman Iron and chronic viral hepatitis Hepatology 25 3 1997 759 768
43. S.J. Cotler, M.P. Bronner, R.D. Press, T.H. Carlson, J.D. Perkins, and M.J. Emond End-stage liver disease without hemochromatosis associated with elevated hepatic iron index J Hepatol 29 2 1998 257 262
44. J. Ludwig, E. Hashimoto, M.K. Porayko, T.P. Moyer, and W.P. Baldus Hemosiderosis in cirrhosis: a study of 447 native livers Gastroenterology 112 3 1997 882 888
45. N.K. Beinker, M.D. Voigt, M. Arendse, J. Smit, I.A. Stander, and R.E. Kirsch Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C J Hepatol 25 5 1996 633 638
46. S.E. Bassett, A.M. Di Bisceglie, B.R. Bacon, R.M. Sharp, S. Govindarajan, and G.B. Hubbard Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees Hepatology 29 6 1999 1884 1892
47. S. Kato, M. Arao, J. Kuriki, T. Tagaya, S. Takiya, and K. Kato Biochemical improvement of chronic hepatitis C after gastrointestinal bleeding Nagoya J Med Sci 57 3-4 1994 153 157
48. A.M. Di Bisceglie, H.L. Bonkovsky, S. Chopra, S. Flamm, R.K. Reddy, and N. Grace Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial Hepatology 32 1 2000 135 138
49. S. Fargion, A.L. Fracanzani, A. Rossini, M. Borzio, O. Riggio, and G. Belloni Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study Am J Gastroenterol 97 5 2002 1204 1210
50. T.L. Fong, S.H. Han, N.C. Tsai, T.R. Morgan, M. Mizokami, and D. Qian A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C J Hepatol 28 3 1998 369 374
51. R.J. Fontana, J. Israel, P. LeClair, B.F. Banner, K. Tortorelli, and N. Grace Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial Hepatology 31 3 2000 730 736
52. D. Guyader, E. Boucher, P. Andre, C. Even, J. Cottereau, and A. Bianchi A pilot study of iron depletion as adjuvant therapy in chronic hepatitis C patients not responding to interferon Am J Gastroenterol 94 6 1999 1696 1698
53. H. Hayashi, T. Takikawa, N. Nishimura, M. Yano, T. Isomura, and N. Sakamoto Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron Am J Gastroenterol 89 7 1994 986 988
54. J.L. Herrera Iron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed to respond to interferon therapy Am J Gastroenterol 94 12 1999 3571 3575
55. D.H. Van Thiel, L. Friedlander, P.J. Molloy, R.J. Kania, S. Fagiuoli, and H.I. Wright Retreatment of hepatitis C interferon non-responders with larger doses of interferon with and without phlebotomy Hepatogastroenterology 43 12 1996 1557 1561
56. G.N. Ioannou, B.Y. Tung, and KV. Kowdley Iron in hepatitis C: villain or innocent bystander? Semin Gastrointest Dis 13 2 2002 95 108
57. M. Sartori, S. Andorno, C. Rigamonti, and R. Boldorini Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome Dig Liver Dis 33 2 2001 157 162
58. M. Yano, H. Hayashi, S. Wakusawa, F. Sanae, T. Takikawa, and Y. Shiono Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C Am J Gastroenterol 97 1 2002 133 137
59. J. Kato, M. Kobune, T. Nakamura, G. Kuroiwa, K. Takada, and R. Takimoto Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet Cancer Res 61 24 2001 8697 8702
60. J.H. Brock, and V. Mulero Cellular and molecular aspects of iron and immune function Proc Nutr Soc 59 4 2000 537 540
61. S. Kakizaki, H. Takagi, N. Horiguchi, M. Toyoda, H. Takayama, and T. Nagamine Iron enhances hepatitis C virus replication in cultured human hepatocytes Liver 20 2 2000 125 128
62. G. Montosi, P. Paglia, C. Garuti, C.A. Guzman, J.M. Bastin, and M.P. Colombo Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis Blood 96 3 2000 1125 1129
63. S. Recalcati, R. Pometta, S. Levi, D. Conte, and G. Cairo Response of monocyte iron regulatory protein activity to inflammation: abnormal behavior in genetic hemochromatosis Blood 91 7 1998 2565 2572
64. G. Weiss Iron and immunity: a double-edged sword Eur J Clin Invest 32 Suppl 1 2002 70 78
65. A.E. Ten Elshof, G.M. Brittenham, K.A. Chorney, M.J. Page, G. Gerhard, and E.E. Cable Gamma delta intraepithelial lymphocytes drive tumor necrosis factor-alpha responsiveness to intestinal iron challenge: relevance to hemochromatosis Immunol Rev 167 1999 223 232
66. M.E. Lorenzo, H.L. Ploegh, and RS. Tirabassi Viral immune evasion strategies and the underlying cell biology Semin Immunol 13 1 2001 1 9
67. K.D. Tardif, and A. Siddiqui Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic replicon-expressing cells J Virol 77 21 2003 11644 11650
68. B.C. Smith, J. Gorve, M.A. Guzail, C.P. Day, A.K. Daly, and A.D. Burt Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C Hepatology 27 6 1998 1695 1699
69. A.L. Martinelli, R.F. Franco, M.G. Villanova, J.F. Figueiredo, M. Secaf, and M.H. Tavella Are haemochromatosis mutations related to the severity of liver disease in hepatitis C virus infection? Acta Haematol 102 3 2000 152 156
70. A. Piperno, A. Vergani, I. Malosio, L. Parma, L. Fossati, and A. Ricci Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations Hepatology 28 4 1998 1105 1109
71. L. Kazemi-Shirazi, C. Datz, T. Maier-Dobersberger, K. Kaserer, F. Hackl, and C. Polli The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C Gastroenterology 116 1 1999 127 134
72. B.Y. Tung, M.J. Emond, M.P. Bronner, S.D. Raaka, S.J. Cotler, and K.V. Kowdley Hepatitis C, iron status, and disease severity: relationship with HFE mutations Gastroenterology 124 2 2003 318 326
73. S.G. Gehrke, W. Stremmel, I. Mathes, H.D. Riedel, K. Bents, and B. Kallinowski Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype J Mol Med 81 12 2003 780 787
74. A. Erhardt, A. Maschner-Olberg, C. Mellenthin, G. Kappert, O. Adams, and A. Donner HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis J Hepatol 38 3 2003 335 342
75. A.T. Merryweather-Clarke, J.J. Pointon, J.D. Shearman, and KJ. Robson Global prevalence of putative haemochromatosis mutations J Med Genet 34 4 1997 275 278
76. H.L. Bonkovsky, N. Troy, K. McNeal, B.F. Banner, A. Sharma, and J. Obando Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C J Hepatol 37 6 2002 848 854
77. A.M. Di Bisceglie, C.A. Axiotis, J.H. Hoofnagle, and B.R. Bacon Measurement of iron status in patients with chronic hepatitis Gastroenterology 102 6 1992 2108 2113
78. A. Piperno, R. D'Alba, S. Fargion, L. Roffi, M. Sampietro, and S. Parma Liver iron concentration in chronic viral hepatitis: a study of 98 patients Eur J Gastroenterol Hepatol 7 12 1995 1203 1208
79. B.R. Bacon, M.W. Fried, and A.M. Di Bisceglie A 39-year-old man with chronic hepatitis, elevated serum ferritin values, and a family history of hemochromatosis Sem Liv Dis 13 1 1993 101 105
80. F. Negro, K. Samii, L. Rubbia-Brandt, R. Quadri, P.J. Male, and J.P. Zarski Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis J Med Virol 60 1 2000 21 27
81. D. Thorburn, G. Curry, R. Spooner, E. Spence, K. Oien, and D. Halls The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis C Gut 50 2 2002 248 252
82. R. Bataller, K.E. North, and D.A. Brenner Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal Hepatology 37 3 2003 493 503